# IMaC - Immune Pathways in Oesophagogastric Cancer

> **NCT06057220** · — · NOT_YET_RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 310 (estimated)

## Conditions studied

- Oesophagogastric Cancer

## Interventions

- **OTHER:** No intervention sample collection only

## Key facts

- **NCT ID:** NCT06057220
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2025-09
- **Final completion:** 2026-09
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2023-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057220, "IMaC - Immune Pathways in Oesophagogastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06057220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*